Visit us at Booth# 2424 at the AACR Annual Meeting in New Orleans, LA.
Horizon Discovery will be presenting a poster with data they derived from the iQue Screener platform. Horizon Discovery is using the iQue Screener platform for immuno-oncology assays and services.
Title: Development of an in vitro screening platform for high capacity evaluation of immunomodulatory drug candidates
Presentation time: Sunday, Apr 17, 2016, 1:00 PM – 5:00 PM
Abstract: Cancer immunotherapy has greatly expanded the therapeutic options against cancer. Recently approved antibody immunotherapies targeting immune-checkpoint molecules expressed on active T cells have shown promise in providing durable clinical anti-tumor responses in a substantial subset of melanoma and lung cancer patients. These clinical successes have prompted renewed efforts to identify efficacious approaches to harness the anti-tumor functions of the immune system. Combination immunotherapy that targets multiple immune-checkpoint molecules and/or combines immunotherapy and chemotherapy will likely lead to improved efficacy and reduced toxicity.